Kristensen B O, Steiness E, Weeke J
Clin Pharmacol Ther. 1978 Jun;23(6):624-9. doi: 10.1002/cpt1978236624.
The effect of abrupt withdrawal of propranolol on serum concentrations of triiodothyronine (T3) and thyroxine (T4) was investigated in 5 patients with uncomplicated essential hypertension. The patients had been treated from 2 to 18 mo before the study was begun. Doses varied from 160 to 480 mg propranolol daily. Four of the patients studied developed tachycardia, sweating, or tremor within 2 to 6 days after withdrawal of propranolol. In 1 patient reversible ischemic ECG changes were recorded. The serum concentrations of free T3 increased in the 4 patients suffering from withdrawal symptoms. The mean increase on the day the symptoms started was 51% (range, 22 to 74, 2 p = 0.01). This increase in serum-free T3 correlated positively with the serum propranolol concentration on the last day propranolol was given (r = 0.91, 2 p = 0.03). In the one patient, who did not develop withdrawal symptoms, the serum concentration of propranolol was very low, and the free T3 level remained unchanged. No significant changes in serum concentrations of free T4 or total thyroid hormones were found in any of the patients. We suggest that the propranolol withdrawal symptoms are, at least partially, caused by an increase in the thyroid hormone, T3.
在5例无并发症的原发性高血压患者中,研究了普萘洛尔突然停药对血清三碘甲状腺原氨酸(T3)和甲状腺素(T4)浓度的影响。在研究开始前,这些患者已接受了2至18个月的治疗。普萘洛尔的剂量为每日160至480毫克。在研究的5例患者中,有4例在停用普萘洛尔后2至6天内出现心动过速、出汗或震颤。1例患者记录到可逆性缺血性心电图改变。出现停药症状的4例患者血清游离T3浓度升高。症状开始当天的平均升高幅度为51%(范围为22%至74%,P = 0.01)。血清游离T3的这种升高与普萘洛尔给药最后一天的血清普萘洛尔浓度呈正相关(r = 0.91,P = 0.03)。在未出现停药症状的1例患者中,血清普萘洛尔浓度非常低,游离T3水平保持不变。所有患者的血清游离T4或总甲状腺激素浓度均未发现显著变化。我们认为,普萘洛尔停药症状至少部分是由甲状腺激素T3增加所致。